TrialClinical lymphoma, myeloma & leukemia2013

Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome.

Apostolia M Tsimberidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.